FL H1345

Excludes cannabis contained within a pharmaceutical product approved by the United States Food and Drug Administration from Schedule I controlled substances list.

Removes previous provisions concerning the scheduling of certain drug products containing cannabidiol, replacing them with FDA-approved drug product provisions.

Adds FDA-approved cannabis pharmaceutical products to the definition of excluded drugs similar to other federal exemptions for chemical preparations and prescription products.

Amends section 893.02 to clarify that "cannabis" definition does not include drug products described in the FDA-approval provision of section 893.03(5)(d).

Takes effect upon becoming law.